• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Deloitte's 2012 survey shows employers plan to shift healthcare costs to employees

Article

While employer-sponsored health benefits are not likely to disappear, changes that shift financial risk to employees are certain.

According to Deloitte, U.S. employers are concerned about continued rising healthcare costs; however, they are unaware of solutions that could improve the safety and quality of care, and simultaneously reduce cost. While employer-sponsored health benefits are not likely to disappear, changes that shift financial risk to employees are certain, according to the company’s survey.

The survey of employers with 50+ workers offering health benefits explores employers’ opinions about the U.S. healthcare system, the Patient Protection and Affordable Care Act (PPACA), and anticipated strategies for employee health benefits coverage and cost containment.

Survey results also revealed:

35% of employers surveyed grade system performance as an “A” or a “B.” Employers hold favorable views about the system’s clinical capabilities and medical innovation, but unfavorable views center on its wastefulness and high costs.

Employers believe that they have a “good” understanding of the PPACA. Familiarity with the individual mandate is the highest (72%). Most employers say their company is “not well prepared” to implement the 2014 provisions of the ACA.

30% think the PPACA is “a good start,” 59% “a step in the wrong direction.” 

To manage healthcare costs, increased cost sharing with employees is considered the optimal strategy. 

When considering healthcare related strategies to reduce the deficit, employers support reforms in medical liability, Medicare and Medicaid, and repeal/delay of the PPACA. Across-the-board cuts in government spending are considered a higher priority than changes to the healthcare system.

Go back to the Managed Healthcare Executive eNews newsletter.

Related Videos
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Related Content
© 2024 MJH Life Sciences

All rights reserved.